In February 2019, the Directive 2011/62/EU of the European Parliament, also known as the Falsified Medicines Directive (FMD), came into effect. The primary objective of the FMD is to prevent the sale of counterfeit medicines through the legal supply chain within the EU. The FMD prescribes essential safety features for prescription medicines, including serialization of individual products and a clear tamper-evident seal as a first-opening protection.
With Diagramm Halbach's pharmaceutical tamper-evident labels, it can be directly determined whether a medication has been opened or is still in its original packaging, ensuring the authenticity of the product. The use of translucent closure labels made of paper, with or without security perforations, is particularly sustainable and serves as a replacement for transparent film labels.
